Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 40, Issue 7, 2001, Pages 762-772

  Keller, Martin B ^a   Ryan, Neal D ^b   Strober, Michael ^c   Klein, Rachel G ^d   Kutcher, Stan P ^e   Birmaher, Boris ^b   Hagino, Owen R ^f   Koplewicz, Harold ^d   Carlson, Gabrielle A ^g   Clarke, Gregory N ^h   Emslie, Grahm J ⁱ   Feinberg, David ^c   Geller, Barbara ^j   Kusumakar, Vivek ^k   Papatheodorou, George ^l   Sack, William H ^m   Sweeney, Michael ⁿ   Wagner, Karen Dineen ^o   Weller, Elizabeth B ^p   Winters, Nancy C ^m   Oakes, Rosemary ^q   McCafferty, James P ^q   more..

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e DALHOUSIE UNIVERSITY   (Canada)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g STONY BROOK UNIVERSITY   (United States)

^h CENTER FOR HEALTH RESEARCH   (United States)

ⁱ UNIVERSITY OF TEXAS AT DALLAS   (United States)

^j WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k Department of Psychiatry   (United States)

^l UNIVERSITY OF TORONTO   (Canada)

^m OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁿ NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^o University of Texas Medical Branch School of Medicine   (United States)

^p CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^q GLAXOSMITHKLINE   (United States)

more..

Author keywords

Adolescent; Imipramine; Major depression; Paroxetine

Indexed keywords

IMIPRAMINE; PAROXETINE; PLACEBO;

ADOLESCENT; ARTICLE; ASTHENIA; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HAMILTON SCALE; HUMAN; INFECTION; INJURY; MAJOR CLINICAL STUDY; MALE; MOOD; MULTICENTER STUDY; NEUROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SCHIZOPHRENIA; SWEATING; VISUAL DISORDER;

EID: 0034961468     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200107000-00010     Document Type: Article

References (55)

1. Multicenter open-label sertraline study in adolescent outpatients with major depression
2. Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression
3. The Sickness Impact Profile: Development and final revision of a health status measure
4. Comorbid ADHD and other disruptive behavior disorders as predictors of response in adolescents treated for major depression
5. Randomized, controlled trial of amitriptyline versus placebo for adolescents with "treatment-resistant" major depression
6. Placebo as a treatment for depression
7. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients
8. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder
9. Paroxetine in major depression: A double-blind trial with imipramine and placebo
10. Treatment of childhood and adolescent disorders
11. A comparison of paroxetine, imipramine, and placebo in depressed outpatients
12. The epidemiology of suicide in adolescents
13. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression
14. A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia
15. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients
16. Clinical management: Imipramine/placebo administration manual
17. Paroxetine in the treatment of depression: A comparison with imipramine and placebo
18. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression
19. Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder
20. Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design
21. Efficacy of tricyclic drugs in treating child and adolescent depression: A meta-analysis
22. The effect of concomitant disorders in childhood depression on predicting treatment response
23. Psychopharmacology of child and adolescent major depression: Present status and future directions
24. Amitriptyline in children with major depressive disorder: A double-blind crossover pilot study
25. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
26. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey
27. Adolescent depression: Controlled desipramine treatment and atypical features
28. Suicidal behaviors and childhood-onset depressive disorders: A longitudinal investigation
29. Prediction of response to fluoxetine and placebo in children and adolescents with major depression: A hypothesis generating study
30. Clinical effects of amitriptyline in adolescent depression: A pilot study
31. Response to desipramine treatment in adolescent depression: A fixed-dose, placebo-controlled trial
32. A randomized, controlled trial of amitriptyline in the acute treatment of a major depression
33. Paroxetine in depressed adolescents with intellectual disability: An open label study
34. An open study of the effects of sertraline on adolescent major depression
35. Predictors of therapeutic benefit from amitriptyline in mild depression: A general practice placebo-controlled trial
36. Imipramine treatment of depressed children: A double-blind pilot study
37. Depression in prepubertal children: Dexamethasone nonsuppression predicts differential response to imipramine vs placebo
38. Unipolar depression in adolescents: Clinical outcome in adulthood
39. Antidepressant efficacy of sertraline: A double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression
40. Paroxetine in children with major depressive disorder: An open trial
41. Effects of paroxetine in depressed adolescents
42. Child and adolescent mood disorders: Experience with serotonin-based therapies
43. Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression
44. A double-blind comparison of paroxetine, imipramine, and placebo in major depression
45. The measurement of behavioral autonomy in adolescence: The autonomous functioning checklist
46. Adolescent depression: A placebo-controlled fluoxetine treatment study and follow-up
47. Sertraline in adolescent depression and dysthymia: A six-month open trial
48. A placebo-controlled trial of paroxetine in the treatment of major depression
49. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder
50. Efficacy of desipramine in depressed outpatients: Response according to research diagnosis criteria diagnoses and severity of illness
51. The pharmacotherapy of depressive illness in adolescents: An open-label comparison of fluoxetine with imipramine-treated historical controls
52. Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?
53. Depressed adolescents grown up